Comparison Between Macrolides and Third-Generation Cephalosporin Preterm Pre-Labor Rupture of Membranes

Zahra  Amir; Sadia  Khan

doi:10.54112/bcsrj.v6i2.1567

Authors

Zahra Amir Department of Obstetrics and Gynaecology, Rawalpindi Teaching Hospital, Pakistan
Sadia Khan Department of Obstetrics and Gynaecology, Benazir Bhutto Hospital Rawalpindi, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v6i2.1567

Keywords:

macrolides, cephalosporin, neonatal sepsis, intrauterine infection, NEC

Abstract

Preterm Pre-Labor Rupture of Membranes (PPROM) has historically been treated with antibiotics. Objective: The study aimed to compare the effectiveness of macrolides (erythromycin) and third-generation cephalosporins (ceftriaxone) in managing Preterm Pre-Labor Rupture of Membranes (PROM). Methodology: A total of 240 pregnant women with preterm premature rupture of membranes (PPROM) occurring between 30–36 weeks of gestation were included in the randomized controlled trial and were assigned into two groups. Group A was given erythromycin (250 mg four times a day for 10 days), while Group B was given ceftriaxone (1g intravenously twice daily for 72 hours). Outcomes included the relative incidence of intrauterine infection, neonatal sepsis, and necrotizing enterocolitis (NEC). Results: The study found a high prevalence of preterm births among women, with 48.8% having PPROM and 32.5% exhibiting chorioamnionitis symptoms. Results demonstrated that Ceftriaxone was associated with better neonatal survival and lower infection rates than Erythromycin (p=0.01). Conclusion: The study concluded that third-generation cephalosporins are more effective in preventing neonatal sepsis and intrauterine infection in those suffering from PPROM. Further large-scale studies are advised to confirm these findings and to adjust antibiotic guidelines.

Downloads

Download data is not yet available.

References

Chatzakis, C., Papatheodorou, S., Sarafidis, K., Dinas, K., Makrydimas, G., & Sotiriadis, A. (2019). Effect on perinatal outcome of prophylactic antibiotics in preterm prelabor rupture of membranes: network meta‐analysis of randomized controlled trials. Ultrasound in Obstetrics and Gynecology, 55(1), 20–31. https://doi.org/10.1002/uog.21884

Dayal, S., Jenkins, S.M. and Hong, P.L., 2024. Preterm and Term Prelabor Rupture of Membranes (PPROM and PROM). In StatPearls [Internet]. StatPearls Publishing.

de Nies, L., Kobras, C.M. and Stracy, M., 2023. Antibiotic-induced collateral damage to the microbiota and associated infections. Nature Reviews Microbiology, 21(12), 789-804. DOI:

Feduniw, S., Gaca, Z., Malinowska, O., Brunets, W., Zgliczyńska, M., Włodarczyk, M., Wójcikiewicz, A. and Ciebiera, M., 2022. The management of pregnancy complicated with the pre-viable preterm and preterm premature rupture of the membranes: what about a limit of neonatal viability? A review. Diagnostics, 12(8), 2025. DOI: https://doi.org/10.3390/diagnostics12082025

Gökçen İşcan, R. and Malvasi, A., 2023. Intrauterine fetal death: management and complications. In Practical Guide to Simulation in Delivery Room Emergencies, 219-243. Cham: Springer International Publishing. DOI: https://doi.org/10.1007/978-3-031-10067-3_12

Khanum, S., Nazia Gul, Maria de Lourdes de Souza, Najma Naz, Stefhanie Conceição de Jesus, Eneida Patrícia Teixeira., 2021. Experiences of Women Hospitalized with Preterm Premature Rupture of Membranes, Peshawar, Pakistan. Saudi J Nurs Health Care, 4(10), DOI: 308-316. DOI: 10.36348/sjnhc.2021.v04i10.002

Kim, J. W., Kim, Y. H., Moon, J. H., Jung, H. A., & Noh, E. J. (2020). The efficacy of third-generation cephalosporin plus metronidazole versus third-generation cephalosporin plus clarithromycin in neonatal outcomes and oxidative stress markers in women with preterm premature rupture of membranes. Clinical and Experimental Obstetrics & Gynecology, 47(2), 194. https://doi.org/10.31083/j.ceog.2020.02.5046

Lorthe, E. and Kayem, G., 2021. Tocolysis in the management of preterm prelabor rupture of membranes at 22–33 weeks of gestation: study protocol for a multicenter, double-blind, randomized controlled trial comparing nifedipine with placebo (TOCOPROM). BMC pregnancy and childbirth, 21(614) 1-13. DOI: https://doi.org/10.1186/s12884-021-04047-2

Lorthe, E., Letouzey, M., Torchin, H., Foix L'Helias, L., Gras‐Le Guen, C., Benhammou, V., Boileau, P., Charlier, C., Kayem, G., 2022. Antibiotic prophylaxis in preterm premature rupture of membranes at 24–31 weeks’ gestation: Perinatal and 2‐year outcomes in the EPIPAGE‐2 cohort. BJOG: An International Journal of Obstetrics & Gynaecology, 129(9), 1560-1573. DOI: https://doi.org/10.1111/1471-0528.17081

Makau, P.M., 2023. Latency, Perinatal and Maternal Outcomes in Conservatively Managed Patients with Preterm Premature Rupture of Membranes at 24-34 Weeks Gestation at Kenyatta National Hospital. URI: http://erepository.uonbi.ac.ke/handle/11295/164499

Merello, M., Lotte, L., Gonfrier, S., dit Trolli, S.E., Casagrande, F., Ruimy, R. and Bongain, A., 2019. Enterobacteria vaginal colonization among patients with preterm premature rupture of membranes from 24 to 34 weeks of gestation and neonatal infection risk. Journal of Gynecology Obstetrics and Human Reproduction, 48(3), 187-191. DOI: https://doi.org/10.1016/j.jogoh.2018.12.007

Navathe, R., Schoen, C.N., Heidari, P., Bachilova, S., Ward, A., Tepper, J., Visintainer, P., Hoffman, M.K., Smith, S., Berghella, V. and Roman, A., 2019. Azithromycin vs erythromycin for the management of preterm premature rupture of membranes. American journal of obstetrics and gynecology, 221(2), 144-148. DOI: https://doi.org/10.1016/j.ajog.2019.03.009

Rasti, S. D., Rochmanti, M., & Primariawan, R. Y. (2020). Cefotaxime vs Ceftriaxone for the Management of Preterm Premature Rupture of Membranes. The International Arabic Journal of Antimicrobial Agents, 10(1). https://doi.org/10.3823/839

Sgayer, I., Francis, Y.N., Miron, D., Shprits, E., Sheffer, V.F., Rechnitzer, H., Lowenstein, L. and Wolf, M.F., 2023. Compared perinatal outcomes of two prophylactic antibiotic regimens for preterm premature rupture of membranes: a randomized controlled trial. American Journal of Obstetrics & Gynecology MFM, 5(5), p.100900. DOI: https://doi.org/10.1016/j.ajogmf.2023.100900

Shahid, M., Nishan, N., Farooqi, S.S., Jabeen, F., Manzoor, H. and Arif, S., 2022. Prevalence and Risk Factors of Preterm Premature Rupture of Membranes in Pregnant Women admitted to Hospital, Pakistan. Pakistan Journal of Medical & Health Sciences, 16(09), 912-912. DOI: https://doi.org/10.53350/pjmhs22169912

Toqueer, M., Javaid, M., Nazneen, Z., Ahmed, K., Hayauddin, H. and Toqueer,. 2022. Risk factors of premature rupture of membranes in Ayub Teaching Hospital: a case-control study. Pakistan Journal of Physiology, 18(1), 44-47. DOI: https://doi.org/10.69656/pjp.v18i1.1357

Tyrnenopoulou, P. and Fthenakis, G.C., 2023. Clinical aspects of bacterial distribution and antibiotic resistance in the reproductive system of equids. Antibiotics, 12(4), 664. DOI: https://doi.org/10.3390/antibiotics12040664

Wolf, M.F., Sgayer, I., Miron, D., Krencel, A., Sheffer, V.F., Idriss, S.S., Sammour, R.N., Peleg, D., Shachar, I.B., Rechnitzer, H. and Bornstein, J., 2020. A novel extended prophylactic antibiotic regimen in preterm pre-labor rupture of membranes: a randomized trial. International Journal of Infectious Diseases, 96, 254-259. DOI: https://doi.org/10.1016/j.ijid.2020.05.005